company background image
CLARI logo

Clariane Informe acción ENXTPA:CLARI

Último precio

€1.88

Capitalización de mercado

€200.7m

7D

13.5%

1Y

-76.1%

Actualizada

29 Apr, 2024

Datos

Finanzas de la empresa +

Clariane SE

Informe acción ENXTPA:CLARI

Capitalización de mercado: €200.7m

Resumen de acción CLARI

Clariane SE ofrece una gama de servicios de asistencia médica y no médica y de apoyo a las personas mayores y a las personas con problemas de salud a corto o largo plazo.

CLARI fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Competidores de Clariane SE

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Clariane
Historical stock prices
Current Share Price€1.88
52 Week High€8.05
52 Week Low€1.32
Beta0.99
1 Month Change27.54%
3 Month Change-21.07%
1 Year Change-76.07%
3 Year Change-94.22%
5 Year Change-94.70%
Change since IPO-94.82%

Noticias y actualizaciones recientes

Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt

Apr 28
Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt

Recent updates

Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt

Apr 28
Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt

Is It Too Late To Consider Buying Clariane SE (EPA:CLARI)?

Dec 06
Is It Too Late To Consider Buying Clariane SE (EPA:CLARI)?

These 4 Measures Indicate That Clariane (EPA:CLARI) Is Using Debt Extensively

Oct 31
These 4 Measures Indicate That Clariane (EPA:CLARI) Is Using Debt Extensively

Calculating The Fair Value Of Clariane SE (EPA:CLARI)

Sep 21
Calculating The Fair Value Of Clariane SE (EPA:CLARI)

What Is Clariane SE's (EPA:CLARI) Share Price Doing?

Jul 29
What Is Clariane SE's (EPA:CLARI) Share Price Doing?

At €6.98, Is It Time To Put Korian (EPA:KORI) On Your Watch List?

Apr 04
At €6.98, Is It Time To Put Korian (EPA:KORI) On Your Watch List?

These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively

Mar 16
These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively

A Look At The Fair Value Of Korian (EPA:KORI)

Jan 16
A Look At The Fair Value Of Korian (EPA:KORI)

Should You Think About Buying Korian (EPA:KORI) Now?

Dec 26
Should You Think About Buying Korian (EPA:KORI) Now?

Does Korian (EPA:KORI) Have A Healthy Balance Sheet?

Dec 01
Does Korian (EPA:KORI) Have A Healthy Balance Sheet?

Is There Now An Opportunity In Korian (EPA:KORI)?

Sep 26
Is There Now An Opportunity In Korian (EPA:KORI)?

Is Korian (EPA:KORI) A Risky Investment?

Aug 31
Is Korian (EPA:KORI) A Risky Investment?

Why Korian (EPA:KORI) Could Be Worth Watching

Jun 14
Why Korian (EPA:KORI) Could Be Worth Watching

We Think Korian (EPA:KORI) Is Taking Some Risk With Its Debt

Mar 30
We Think Korian (EPA:KORI) Is Taking Some Risk With Its Debt

Korian (EPA:KORI) Has A Somewhat Strained Balance Sheet

Dec 24
Korian (EPA:KORI) Has A Somewhat Strained Balance Sheet

Korian (EPA:KORI) Seems To Be Using A Lot Of Debt

Sep 25
Korian (EPA:KORI) Seems To Be Using A Lot Of Debt

Why Korian (EPA:KORI) Could Be Worth Watching

Jul 15
Why Korian (EPA:KORI) Could Be Worth Watching

Does Korian (EPA:KORI) Have A Healthy Balance Sheet?

Jun 18
Does Korian (EPA:KORI) Have A Healthy Balance Sheet?

Are Investors Undervaluing Korian (EPA:KORI) By 42%?

May 05
Are Investors Undervaluing Korian (EPA:KORI) By 42%?

These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively

Mar 18
These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively

Korian (EPA:KORI) Just Released Its Yearly Earnings: Here's What Analysts Think

Feb 28
Korian (EPA:KORI) Just Released Its Yearly Earnings: Here's What Analysts Think

We Wouldn't Rely On Korian's (EPA:KORI) Statutory Earnings As A Guide

Feb 02
We Wouldn't Rely On Korian's (EPA:KORI) Statutory Earnings As A Guide

If You Had Bought Korian's (EPA:KORI) Shares A Year Ago You Would Be Down 23%

Jan 13
If You Had Bought Korian's (EPA:KORI) Shares A Year Ago You Would Be Down 23%

Is There An Opportunity With Korian's (EPA:KORI) 46% Undervaluation?

Dec 28
Is There An Opportunity With Korian's (EPA:KORI) 46% Undervaluation?

What Does Korian's (EPA:KORI) Share Price Indicate?

Dec 15
What Does Korian's (EPA:KORI) Share Price Indicate?

Rentabilidad de los accionistas

CLARIFR HealthcareMercado FR
7D13.5%-0.4%0.4%
1Y-76.1%-7.2%3.4%

Rentabilidad vs. Industria: CLARI obtuvo unos resultados inferiores a los del sector French Healthcare , que el año pasado arrojó un rendimiento del -7.2%.

Rentabilidad vs. Mercado: CLARI obtuvo unos resultados inferiores a los del mercado French, que fue del 4% el año pasado.

Volatilidad de los precios

Is CLARI's price volatile compared to industry and market?
CLARI volatility
CLARI Average Weekly Movement13.2%
Healthcare Industry Average Movement4.9%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.2%
10% least volatile stocks in FR Market2.3%

Precio estable de las acciones: El precio de las acciones de CLARI ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de CLARI(12%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de French.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
2001n/aSophie Boissardwww.clariane.com

Clariane SE ofrece una gama de servicios de asistencia y apoyo médicos y no médicos para ancianos y personas con problemas de salud a corto o largo plazo. La empresa gestiona residencias de la tercera edad, clínicas especializadas, residencias asistidas y viviendas compartidas para personas mayores, y ofrece servicios de atención domiciliaria, apoyo y hospitalización. Opera aproximadamente centros y redes de asistencia sanitaria en Francia, Alemania, Italia, España, Países Bajos, Bélgica y Reino Unido.

Resumen de fundamentos de Clariane SE

¿Cómo se comparan los beneficios e ingresos de Clariane con su capitalización de mercado?
Estadísticas fundamentales de CLARI
Capitalización bursátil€200.75m
Beneficios(TTM)-€92.44m
Ingresos (TTM)€5.00b

0.0x

Ratio precio-ventas (PS)

-2.2x

Ratio precio-beneficio (PE)

¿Está CLARI sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de CLARI
Ingresos€5.00b
Coste de los ingresos€3.43b
Beneficio bruto€1.57b
Otros gastos€1.66b
Beneficios-€92.44m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-0.87
Margen bruto31.41%
Margen de beneficio neto-1.85%
Ratio deuda/patrimonio115.1%

¿Cómo se ha desempeñado CLARI a largo plazo?

Ver rendimiento histórico y comparativa